BridgeMD
New treatment option for Hypotension Drug-Induced
Official title A Prospective Study of Vasopressor on Cerebral Oxygenation During General Anesthesia
ClinicalTrials.gov ID: NCT06334549
What this study is testing
What is Ephedrine-P?
Ephedrine-P is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for hypotension drug-induced.
Also referred to as vasopressor.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to investigate whether norepinephrine(N), phenylephrine(P) or ephedrine(E) have different effect on cerebral oxygenation in abdominal surgery with propofol or sevoflurane.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- ASA I-III, age 18-80 years
- Elective abdominal surgery
- Signed informed consent
You likely can't join if
- ASA≥IV
- Preoperative unstable blood hemodynamics
- Allergy to ephedrine, phenylephrine or norepinephrine
- Decrease in MAP \<20%
- Severe cardiovascular disorder
The study team makes the final eligibility decision.
Where it's taking place
- Dalian, Liaoning, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dalian, Liaoning, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.